Nitrogen Heterocycles in Cancer Therapy
- 1st Edition - October 14, 2025
- Latest edition
- Editors: Sanjeev Kumar Sahu, Ankur Vaidya
- Language: English
Nitrogen Heterocycles in Cancer Therapy explores the vast array of recently discovered nitrogen-containing heterocyclic compounds utilized in combating cancer. This compre… Read more
A significant emphasis is placed on crucial evaluation techniques such as in-vitro cell culture and in-vivo animal models, providing insights into the performance of these compounds in combating cancer. Particularly noteworthy is the inclusion of clinical study reports detailing the efficacy of various drug candidates across different cancer conditions, coupled with an analysis of their global market impact and pharmacoeconomics. Offering profound insights, this book emerges as an indispensable resource for researchers, clinicians, and students alike.
- Equips readers with practical solutions to daily challenges in cancer therapy, bridging the gap between organic chemistry and clinical practice
- Serves as an essential reference for anyone seeking to navigate the dynamic landscape of cancer therapy using innovative nitrogen-containing compounds
- Covers nitrogen heterocycles, encompassing design, synthesis, and mechanisms, providing a thorough understanding of their pivotal role in cancer therapy
2. Three and Four-Member Nitrogen-Containing Heterocyclic Compounds as Anticancer Agents
3. Five membered nitrogen-containing heterocyclic compounds (pyrrole and pyrazole derivatives) as anticancer compounds
4. Six membered nitrogen-containing heterocyclic compounds (Pyridine, pyrimidine, piperidine and triazine) as anticancer compounds
5. Azoles (triazole and imidazole) scaffolds in anticancer drug design
6. Purine derivatives in cancer therapy
7. Indole scaffolds in anticancer drug discovery
8. Benzimidazole, benzothiazole and benzoxazole derivatives as potential anticancer agents
9. Quinoline, isoquinoline and quinoxaline derivatives as promising anticancer agents
10. Miscellaneous fused heterocyclic compounds (β-lactam derivatives, Carbazoles, Isatin derivatives, Pyrrolo-Benzodiazepines, Pyrido[2,3-d] Pyrimidine Derivatives) as anticancer compounds
- Edition: 1
- Latest edition
- Published: October 14, 2025
- Language: English
SS
Sanjeev Kumar Sahu
AV
Ankur Vaidya
Dr. Ankur Vaidya did his graduation, post-graduation and PhD from Dept. of Pharmaceutical Sciences, Dr. H. S. Gour University, Sagar (M.P.) in 2004, 2008 and 2013 respectively. Dr. Vaidya has a teaching and research experience of many years and is currently working as Asst. Professor in Faculty of Pharmacy UPUMS, Saifai, Etawah (U.P.) India. Dr. Ankur has a key research interest in discovery of new anticancer agents with novel targets and published dozens outstanding publications in various International journals. Dr Vaidya has credited as reviewer of international journals of repute in the field of Pharmaceutical sciences. Dr. Ankur has guided several postgraduate theses and was also the recipient of AICTE-NDF (National Doctorate Fellowship) fellowship for PhD research project. Dr. Vaidya has published nternational book chapters, one International book authored and 1 national book. Dr. Ankur has participated/presented in various National and International conferences.